PDL BioPharma (PDLI) 6.39 -0.10

PDL BioPharma, Inc.
(PDLI) 6.39 -0.10

Last Trade:	6.39	Day Range:	6.35 - 6.48
Trade Time:	08:02PM	52wk Range:	4.66 - 6.66
Prev. Close:	6.49	Market Cap:	893.54M
Open:	6.45	Div Yield:	9.39
Volume:	1338669	PE:
EPS:	0.78

The Latest On PDLI

PDL BioPharma Announces Exchange of Its 2.875% Convertible Senior Notes due February 15, 2015 2/2/12 5:08pm

PDL BioPharma Announces Settlement and Final Results of its Exchange Offer 1/6/12 7:23am

Market Roundup 12/19/11 10:17am

Benzinga's Top Pre-Market Losers 12/19/11 8:24am

PDL BioPharma Shares Down In Pre-Market On Downbeat Revenue Forecast 12/19/11 8:05am

PDL BioPharma Provides Q4 Revenue Guidance of $72M vs $82.46M 12/19/11 7:01am

Market Update 12/12/11 9:31am

PDL BioPharma Announces Departure of Chief Financial Officer 12/12/11 7:30am

PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes 12/12/11 7:01am

PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes 12/7/11 7:00am

5 Small-Cap NASDAQ Stocks with Amazing Dividends 11/15/11 2:48pm

PDL BioPharma Inc. Announces Exchange Offer for Its 2.875% Convertible Senior Notes Due February 15, 2015 11/15/11 7:03am

PDL BioPharma Announces Exchange of Its 2.875% Convertible Senior Notes due February 15, 2015 2/2/12

PDL BioPharma Announces Settlement and Final Results of its Exchange Offer 1/6/12

Market Roundup 12/19/11

Benzinga's Top Pre-Market Losers 12/19/11

PDL BioPharma Shares Down In Pre-Market On Downbeat Revenue Forecast 12/19/11

PDL BioPharma Provides Q4 Revenue Guidance of $72M vs $82.46M 12/19/11

Market Update 12/12/11

PDL BioPharma Announces Departure of Chief Financial Officer 12/12/11

PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes 12/12/11

PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes 12/7/11

5 Small-Cap NASDAQ Stocks with Amazing Dividends 11/15/11

PDL BioPharma Inc. Announces Exchange Offer for Its 2.875% Convertible Senior Notes Due February 15, 2015 11/15/11

5 Small-Cap NASDAQ Stocks with Amazing Dividends 11/15/11

Some High Dividend Paying Stocks For A Weak Market (MO, MRK, JNJ, NLY) 3/16/11

Top 4 Small-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio (PDLI, EXEL, SHP, VPHM) 12/28/10

A Peek Into The Market Before The Trading Starts 12/1/10

A Peek Into The Market Before The Trading Starts 10/4/10

Benzinga’s Top Pre-Market NASDAQ Losers (JAZZ, SAFM, PDLI, COCO) 8/23/10

Benzinga’s Top Pre-Market NASDAQ Losers (PSTB, TSTC, PDLI, ARNA) 8/13/10

Five High Dividend Yield Stocks (AGNC, CIM, NLY, PDLI, ANH) 8/9/10

Top 5 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margins (QLTI, PDLI, TECH, GILD, AMGN) 6/3/10

Top 5 Stocks In The Healthcare Sector With Lowest PEG (PDLI, PRX, MDCO, UTHR, CPIX) 4/19/10

Top 5 Small-Cap NASDAQ Stocks with Lowest PEG Ratio (PDLI, SOLR, YONG, FEED, FUQI) 4/1/10

Top 5 Small-Cap NASDAQ Stocks with Lowest PEG Ratio (YONG, PDLI, HOGS, CMED, TRLG) 2/10/10

Benzinga's Top Upgrades (FFIV, LLTC, PDLI, MU) 1/20/11

Global Hunter Downgrades PDLI To Accumulate 1/5/11

A Peek Into The Market Before The Trading Starts 12/1/10

J.P. Morgan Remains Uncertain on PDL BioPharma 11/11/10

A Peek Into The Market Before The Trading Starts 10/4/10

Oppenheimer's Current Biotech Ratings 9/13/10

Snap Commentaries From Oppenheimer 9/2/10

Benzinga’s Top Pre-Market NASDAQ Losers (JAZZ, SAFM, PDLI, COCO) 8/23/10

Top 5 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margins (QLTI, PDLI, TECH, GILD, AMGN) 6/3/10

Trade PDLI
NOW!

Partner Headlines

Seth Klarman Latest Portfolio: Buys IDIX, NG, ANV, Sells PDLI, ALR, BBEP 2/10/12

The Best Yielding Healthcare Dividend Stocks with Fastest Earnings Growth 2/2/12

10 High Margin Healthcare Dividend Shares 1/2/12

Seth Klarman's Stocks with Dividend Yield Over 4% 12/13/11

Don't Get Trapped by High Dividends - Analyst Blog 12/12/11

An Aggregated Top Yield Portfolio of Warren Buffett, Wilbur Ross, Seth Klarman and George Soros 11/16/11

Hedge Fund 13F Stock Picks: Profiting From Idea Season 11/15/11

Seth Klarman's Baupost Group Buys HPQ, BP, NWS, GNW, NG 11/14/11

PDLI Beats by a Penny on Lower Costs - Analyst Blog 11/10/11

Seth Klarman Value Portfolio 10/29/11

Seth Klarman Value Portfolio: PDLI, BP, MSFT, ITRN, BBEP 10/29/11

Press Releases

PDL BioPharma to Present at the 14th Annual BIO CEO & Investor Conference 2/7/12 Newswire Story

PDL BioPharma Announces Exchange of Its 2.875% Convertible Senior Notes due February 15, 2015 2/2/12 Newswire Story

PDL BioPharma Announces 2012 Regular Quarterly Dividends 1/24/12 Newswire Story

PDL BioPharma Announces Settlement and Final Results of its Exchange Offer 1/5/12 Newswire Story

PDL BioPharma to Present at the 30th Annual JP Morgan Healthcare Conference 1/5/12 Newswire Story

PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer 1/3/12 Newswire Story

PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million 12/19/11 Newswire Story

PDL BioPharma Completes Regular Quarterly Dividend Payment 12/15/11 Newswire Story

PDL BioPharma Announces Departure of Chief Financial Officer 12/12/11 Newswire Story

PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes 12/12/11 Newswire Story

PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes 12/7/11 Newswire Story

PDL BioPharma Inc. Announces Exchange Offer for Its 2.875% Convertible Senior Notes Due February 15, 2015 11/15/11 Newswire Story

Get the latest PDLI stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for PDL BioPharma, Inc. stock price.

PDL BioPharma, Inc. by YCharts

PDL BioPharma (PDLI) 6.39 -0.10

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On PDLI

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social